You are here

News

2026

Smart Cells - FamiCord Group
Nov 2026   Over 25 years, Smart Cells has grown from a pioneering UK cord blood bank into part of a major international network for stem cell preservation and delivery of therapies.
Interview with the founders of Cell BioEngines
Nov 2026   Cell BioEngines is developing an expanded cord blood product SAVI-CORD™ that is sourced from HLA-homozygous cord blood units. SAVI-CORD™ is intended to provide an off-the-shelf graft source for patients that need a transplant asap. Their initial target is patients that relapse after a stem cell transplant or CAR-T therapy. Longer term, Cell BioEngines  hopes to provide a scalable source of cord blood transplants that match multiple patients.
The Business of Selling Placentas Collapsed in 2026
Nov 2026   In 2026, the placenta boom has gone bust, due to US government caps on the price of placenta products. Many organizations have stopped collecting placenta donations, and many physicians have stopped using placenta products for grafts to treat chronic wounds.
Royan: Treating Autism with Donated UC-MSC product Whartocell
Oct 2026   The product Whartocell® containing umbilical cord mesenchymal stromal cells (UC-MSC) has market approval in Iran for certain diagnoses. A newly-published clinical trial showed that children with autism had significant improvements after a single intrathecal dose of this product.
image credit: Radiation Affiliates Imaging
Oct 2026   Most obstetricians in the United States perform two routine ultrasounds during uncomplicated, low-risk pregnancies. 
NEXT Biosciences: Treating Autism with Autologous UC-MSC
Sep 2026   A boy with autism who previously struggled to speak is now a chatterbox. He was the first child treated in a program in South Africa where children receive intrathecal injections of MSCs grown from their own cryopreserved umbilical cord tissue.
Implementing Cord Blood Therapy for Cerebral Palsy in the US
Sep 2026   Clinicians who work with children that have cerebral palsy have identified five theme topics that impact the ability to implement cord blood therapy in more hospitals.
From Bank to Bedside: ReeLabs of India
Aug 2026   ReeLabs of India stores stem cells from six perinatal sources and four adult sources. ReeLabs is also at the forefront of the regenerative medicine revolution in India. They run clinical trials of cell therapies and offer a patented anti-aging treatment.
Delivering the Placenta
Aug 2026   The placenta is destined to be a temporary organ: when its time is up, a cascade of signals tells the mother's body to expel the placenta after birth. Safe delivery of the placenta is essential to prevent excessive bleeding after birth.
AABB 2026 Annual Meeting Registration
Jul 2026   Registration is now open for the AABB 2026 Annual Meeting, to be held Oct. 17-19 in Atlanta, Georgia, USA.